Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel + cisplatin concurrent chemoradiotherapy for anal canal cancer
ChiCTR1900020618Phase 2Recruiting
- Sponsor
- The Sixth Affiliated Hospital of Sun Yat-Sen University
- Start
- Jun 2018
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of docetaxel and cisplatin in anal squamous cell carcinoma (SCCA), sponsored by The Sixth Affiliated Hospital of Sun Yat-Sen University. Started Jun 2018; status: recruiting.
02
Drugs
docetaxelcisplatin
03
Conditions
anal squamous cell carcinoma (SCCA)
Beyond the preview
Go deeper on ChiCTR1900020618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900020618.